{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T22:45:13Z","timestamp":1790289913723,"version":"4.1.0"},"reference-count":65,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Institute of Health","award":["DA014789"],"award-info":[{"award-number":["DA014789"]}]},{"name":"National Institute of Health","award":["MH063266"],"award-info":[{"award-number":["MH063266"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.neuropharm.2011.06.014","type":"journal-article","created":{"date-parts":[[2011,7,4]],"date-time":"2011-07-04T15:33:58Z","timestamp":1309793638000},"page":"167-176","source":"Crossref","is-referenced-by-count":123,"title":["Blockade of kappa opioid receptors attenuates the development of depressive-like behaviors induced by cocaine withdrawal in rats"],"prefix":"10.1016","volume":"62","author":[{"given":"Elena","family":"Chartoff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Sawyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Rachlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dave","family":"Potter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Pliakas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William A.","family":"Carlezon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2011.06.014_bib1","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/nn872","article-title":"Neurobiological evidence for hedonic allostasis associated with escalating cocaine use","volume":"5","author":"Ahmed","year":"2002","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2011.06.014_bib2","doi-asserted-by":"crossref","first-page":"18396","DOI":"10.1073\/pnas.0910180106","article-title":"Zyklophin, a systemically active selective kappa opioid receptor peptide antagonist with short duration of action","volume":"106","author":"Aldrich","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2011.06.014_bib3","series-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"2000"},{"key":"10.1016\/j.neuropharm.2011.06.014_bib4","doi-asserted-by":"crossref","first-page":"11017","DOI":"10.1523\/JNEUROSCI.19-24-11017.1999","article-title":"Role of adenosine A2 receptors in brain stimulation reward under baseline conditions and during cocaine withdrawal in rats","volume":"19","author":"Baldo","year":"1999","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2011.06.014_bib5","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/BF00444692","article-title":"Evidence that the aversive effects of opioid antagonists and kappa-agonists are centrally mediated","volume":"98","author":"Bals-Kubik","year":"1989","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2011.06.014_bib6","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0165-6147(02)02086-2","article-title":"A\u00a0\u2018crash\u2019 course on psychostimulant withdrawal as a model of depression","volume":"23","author":"Barr","year":"2002","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2011.06.014_bib7","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s00213-005-0167-4","article-title":"Differential effects of the novel kappa opioid receptor antagonist, JDTic, on reinstatement of cocaine-seeking induced by footshock stressors vs cocaine primes and its antidepressant-like effects in rats","volume":"183","author":"Beardsley","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2011.06.014_bib8","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1037\/0003-066X.41.7.765","article-title":"Understanding and preventing relapse","volume":"41","author":"Brownell","year":"1986","journal-title":"Am. Psychol."},{"key":"10.1016\/j.neuropharm.2011.06.014_bib9","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.brainres.2009.08.062","article-title":"The dynorphin\/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors","volume":"1314","author":"Bruchas","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2011.06.014_bib10","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000124618","article-title":"Pharmacological characterization of opioid receptors influencing the secretion of corticotrophin releasing factor in the rat","volume":"44","author":"Buckingham","year":"1986","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.neuropharm.2011.06.014_bib11","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1124\/jpet.105.092304","article-title":"Depressive-like effects of the kappa-opioid receptor agonist salvinorin A on behavior and neurochemistry in rats","volume":"316","author":"Carlezon","year":"2006","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2011.06.014_bib12","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1038\/nprot.2007.441","article-title":"Intracranial self-stimulation (ICSS) in rodents to study the neurobiology of motivation","volume":"2","author":"Carlezon","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.neuropharm.2011.06.014_bib13","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1126\/science.282.5397.2272","article-title":"Regulation of cocaine reward by CREB","volume":"282","author":"Carlezon","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2011.06.014_bib14","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0006-3223(01)01344-0","article-title":"Antidepressant-like effects of cytidine in the forced swim test in rats","volume":"51","author":"Carlezon","year":"2002","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.06.014_bib15","doi-asserted-by":"crossref","first-page":"5029","DOI":"10.1523\/JNEUROSCI.0854-05.2005","article-title":"Endogenous kappa-opioid receptor systems regulate mesoaccumbal dopamine dynamics and vulnerability to cocaine","volume":"25","author":"Chefer","year":"2005","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2011.06.014_bib16","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jneumeth.2005.12.018","article-title":"Quantitative no-net-flux microdialysis permits detection of increases and decreases in dopamine uptake in mouse nucleus accumbens","volume":"155","author":"Chefer","year":"2006","journal-title":"J.\u00a0Neurosci. Methods"},{"key":"10.1016\/j.neuropharm.2011.06.014_bib17","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/BF02245592","article-title":"Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants","volume":"121","author":"Detke","year":"1995","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2011.06.014_bib18","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s00213-010-1836-5","article-title":"Depressive-like effects of the kappa opioid receptor agonist salvinorin A are associated with decreased phasic dopamine release in the nucleus accumbens","volume":"210","author":"Ebner","year":"2010","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2011.06.014_bib19","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/sj.npp.1301470","article-title":"Enhanced sensitivity to stress and drug\/alcohol craving in abstinent cocaine-dependent individuals compared to social drinkers","volume":"33","author":"Fox","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2011.06.014_bib20","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1126\/science.2011738","article-title":"Cocaine addiction: psychology and neurophysiology","volume":"251","author":"Gawin","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2011.06.014_bib21","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1001\/archpsyc.1986.01800020013003","article-title":"Abstinence symptomatology and psychiatric diagnosis in cocaine abusers. Clinical observations","volume":"43","author":"Gawin","year":"1986","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.06.014_bib22","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1460-9568.2005.04538.x","article-title":"LTP in the lateral amygdala during cocaine withdrawal","volume":"23","author":"Goussakov","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2011.06.014_bib23","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/S0022-3565(25)11434-1","article-title":"Extremely long-lasting antagonistic actions of nor-binaltorphimine (nor-BNI) in the mouse tail-flick test","volume":"260","author":"Horan","year":"1992","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2011.06.014_bib24","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/syn.890130408","article-title":"Molecular alterations in the neostriatum of human cocaine addicts","volume":"13","author":"Hurd","year":"1993","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2011.06.014_bib25","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00213-010-1803-1","article-title":"Effect of the selective kappa-opioid receptor antagonist JDTic on nicotine antinociception, reward, and withdrawal in the mouse","volume":"210","author":"Jackson","year":"2010","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2011.06.014_bib26","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.tips.2007.01.008","article-title":"Brain reward systems and compulsive drug use","volume":"28","author":"Kenny","year":"2007","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2011.06.014_bib27","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.brainres.2009.09.074","article-title":"Dynorphin, stress, and depression","volume":"1314","author":"Knoll","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2011.06.014_bib28","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1124\/jpet.107.127415","article-title":"Anxiolytic-like effects of kappa-opioid receptor antagonists in models of unlearned and learned fear in rats","volume":"323","author":"Knoll","year":"2007","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2011.06.014_bib63","doi-asserted-by":"crossref","unstructured":"Knoll, A.T., Muschamp, J.W., Sillivan, S.E., Ferguson, D., Dietz, D.M., Meloni, E.G., Carroll, F.I., Nestler, E.J., Konradi, C., Carlezon, W.A., Jr. Kappa opioid receptor signaling in the basolateral amygdala regulates conditioned fear and anxiety in rats. Biol. Psychiatry, in press.","DOI":"10.1016\/j.biopsych.2011.03.017"},{"key":"10.1016\/j.neuropharm.2011.06.014_bib29","first-page":"427","article-title":"Environmental-enrichment-related variations in behavioral, biochemical, and physiologic responses of Sprague-Dawley and Long Evans rats","volume":"49","author":"Konkle","year":"2010","journal-title":"J.\u00a0Amer. Assoc. Lab. Anim. Sci."},{"key":"10.1016\/j.neuropharm.2011.06.014_bib30","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0893-133X(00)00195-0","article-title":"Drug addiction, dysregulation of reward, and allostasis","volume":"24","author":"Koob","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2011.06.014_bib31","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0376-8716(98)00064-7","article-title":"Drug dependence: stress and dysregulation of brain reward pathways","volume":"51","author":"Kreek","year":"1998","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuropharm.2011.06.014_bib32","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1523\/JNEUROSCI.4458-07.2008","article-title":"The dysphoric component of stress is encoded by activation of the dynorphin kappa-opioid system","volume":"28","author":"Land","year":"2008","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2011.06.014_bib33","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1124\/jpet.102.046433","article-title":"Antidepressant-like effects of kappa-opioid receptor antagonists in the forced swim test in rats","volume":"305","author":"Mague","year":"2003","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2011.06.014_bib34","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/S0022-3565(25)24454-8","article-title":"Chronic administration of a cocaine \u201cbinge\u201d alters basal extracellular levels in male rats: an in\u00a0vivo microdialysis study","volume":"272","author":"Maisonneuve","year":"1995","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2011.06.014_bib35","first-page":"2445","article-title":"Autoradiographic differentiation of mu, delta, and kappa opioid receptors in the rat forebrain and midbrain","volume":"7","author":"Mansour","year":"1987","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2011.06.014_bib36","first-page":"17","article-title":"Postcocaine anhedonia. An animal model of cocaine withdrawal","volume":"4","author":"Markou","year":"1991","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2011.06.014_bib37","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0893-133X(97)00113-9","article-title":"Neurobiological similarities in depression and drug dependence: a self-medication hypothesis","volume":"18","author":"Markou","year":"1998","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2011.06.014_bib38","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0169-328X(97)00338-0","article-title":"Repeated administration of cocaine, nicotine and ethanol: effects on preprodynorphin, preprotachykinin A and preproenkephalin mRNA expression in the dorsal and the ventral striatum of the rat","volume":"54","author":"Mathieu-Kia","year":"1998","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.neuropharm.2011.06.014_bib39","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/sj.npp.1300860","article-title":"Prior activation of kappa opioid receptors by U50,488 mimics repeated forced swim stress to potentiate cocaine place preference conditioning","volume":"31","author":"McLaughlin","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2011.06.014_bib40","doi-asserted-by":"crossref","first-page":"5674","DOI":"10.1523\/JNEUROSCI.23-13-05674.2003","article-title":"Kappa opioid receptor antagonism and prodynorphin gene disruption block stress-induced behavioral responses","volume":"23","author":"McLaughlin","year":"2003","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2011.06.014_bib41","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1523\/JNEUROSCI.5973-10.2011","article-title":"Activation of CREB in the nucleus accumbens shell produces anhedonia and resistance to extinction of fear in rats","volume":"31","author":"Muschamp","year":"2011","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2011.06.014_bib64","series-title":"Guide for the Care and Use of Laboratory Animals","author":"National Academy Press","year":"1996"},{"key":"10.1016\/j.neuropharm.2011.06.014_bib42","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/s00213-004-1878-7","article-title":"Effects of the kappa opioid agonist U50,488 and the kappa opioid antagonist nor-binaltorphimine on choice between cocaine and food in rhesus monkeys","volume":"176","author":"Negus","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2011.06.014_bib43","doi-asserted-by":"crossref","first-page":"10883","DOI":"10.1523\/JNEUROSCI.22-24-10883.2002","article-title":"Inhibition of cAMP response element-binding protein or dynorphin in the nucleus accumbens produces an antidepressant-like effect","volume":"22","author":"Newton","year":"2002","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2011.06.014_bib65","series-title":"The Rat Brain in Stereotactic Coordinates","author":"Paxinos","year":"1986"},{"key":"10.1016\/j.neuropharm.2011.06.014_bib44","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1126\/science.3016896","article-title":"Psychotomimesis mediated by kappa opiate receptors","volume":"233","author":"Pfeiffer","year":"1986","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2011.06.014_bib45","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.neuroscience.2010.04.060","article-title":"Acute withdrawal from chronic escalating-dose binge cocaine administration alters kappa opioid receptor stimulation of [35S] guanosine 5\u2032-O-[gamma-thio]triphosphate acid binding in the rat ventral tegmental area","volume":"169","author":"Piras","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2011.06.014_bib46","doi-asserted-by":"crossref","first-page":"7397","DOI":"10.1523\/JNEUROSCI.21-18-07397.2001","article-title":"Altered responsiveness to cocaine and increased immobility in the forced swim test associated with elevated cAMP response element-binding protein expression in nucleus accumbens","volume":"21","author":"Pliakas","year":"2001","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2011.06.014_bib47","doi-asserted-by":"crossref","unstructured":"Potter, D., Damez-Werno, D., Carlezon Jr., W.A., Cohen, B.M., Chartoff, E.C., Repeated exposure to the kappa-opioid receptor agonist salvinorin A modulates extracellular signal regulated kinase and reward sensitivity. Biol. Psychiatry. in press.","DOI":"10.1016\/j.biopsych.2011.05.021"},{"key":"10.1016\/j.neuropharm.2011.06.014_bib48","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1126\/science.6129700","article-title":"Immunoreactive dynorphin-(1\u20138) and corticotropin-releasing factor in subpopulation of hypothalamic neurons","volume":"219","author":"Roth","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2011.06.014_bib49","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0165-0173(00)00024-2","article-title":"Stress-induced relapse to heroin and cocaine seeking in rats: a review","volume":"33","author":"Shaham","year":"2000","journal-title":"Brain Res. Brain Res. Rev."},{"key":"10.1016\/j.neuropharm.2011.06.014_bib50","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.pharmthera.2007.06.011","article-title":"Dynorphin and the pathophysiology of drug addiction","volume":"116","author":"Shippenberg","year":"2007","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2011.06.014_bib51","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1001\/archpsyc.63.3.324","article-title":"Stress-induced cocaine craving and hypothalamic-pituitary-adrenal responses are predictive of cocaine relapse outcomes","volume":"63","author":"Sinha","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.06.014_bib52","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0169-328X(93)90133-A","article-title":"\u2018Binge\u2019 cocaine administration induces a sustained increase of prodynorphin mRNA in rat caudate-putamen","volume":"19","author":"Spangler","year":"1993","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.neuropharm.2011.06.014_bib53","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00213-003-1680-y","article-title":"Effects of kappa-opioid receptor ligands on intracranial self-stimulation in rats","volume":"172","author":"Todtenkopf","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2011.06.014_bib54","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.biopsych.2008.05.029","article-title":"The kappa-opioid agonist U69,593 blocks cocaine-induced enhancement of brain stimulation reward","volume":"64","author":"Tomasiewicz","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.06.014_bib55","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/S0022-3565(25)22549-6","article-title":"Time course of the development of behavioral sensitization and dopamine receptor up-regulation during binge cocaine administration","volume":"270","author":"Unterwald","year":"1994","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2011.06.014_bib56","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1124\/jpet.107.125484","article-title":"Kappa agonist-induced reinstatement of cocaine seeking in squirrel monkeys: a role for opioid and stress-related mechanisms","volume":"323","author":"Valdez","year":"2007","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2011.06.014_bib57","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1527-3458.2003.tb00248.x","article-title":"A\u00a0review of the properties of spiradoline: a potent and selective k-opioid receptor agonist","volume":"9","author":"Wadenberg","year":"2003","journal-title":"CNS Drug Rev."},{"key":"10.1016\/j.neuropharm.2011.06.014_bib58","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/sj.npp.1301438","article-title":"Pharmacological evidence for a motivational role of kappa-opioid systems in ethanol dependence","volume":"33","author":"Walker","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2011.06.014_bib59","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00213-010-1825-8","article-title":"The role of the dynorphin\u2013\u03ba opioid system in the reinforcing effects of drugs of abuse","volume":"210","author":"Wee","year":"2010","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2011.06.014_bib60","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s00213-009-1563-y","article-title":"Inhibition of kappa opioid receptors attenuated increased cocaine intake in rats with extended access to cocaine","volume":"205","author":"Wee","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2011.06.014_bib61","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/syn.10198","article-title":"Differential gene expression in the rat caudate putamen after \u201cbinge\u201d cocaine administration: advantage of triplicate microarray analysis","volume":"48","author":"Yuferov","year":"2003","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2011.06.014_bib62","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.neuroscience.2008.03.023","article-title":"Effects of cocaine place conditioning, chronic escalating-dose \u201cbinge\u201d pattern cocaine administration and acute withdrawal on orexin\/hypocretin and preprodynorphin gene expressions in lateral hypothalamus of Fischer and Sprague-Dawley rats","volume":"153","author":"Zhou","year":"2008","journal-title":"Neuroscience"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390811002589?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390811002589?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T22:48:17Z","timestamp":1741301297000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390811002589"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":65,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0028390811002589"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2011.06.014","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}